Gene · 53369
Papers1,954
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,954
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Prospective randomized comparative study of the effect of pemafibrate add-on or double statin dose on small dense low-density lipoprotein-cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy. | J Diabetes Investig | 2023 | 37647503 | PubTator, text mining | PubMed |
| Increased Expression of miR-223-3p and miR-375-3p and Anti-Inflammatory Activity in HDL of Newly Diagnosed Women in Advanced Stages of Breast Cancer. | Int J Mol Sci | 2023 | 37628945 | PubTator, text mining | PubMed |
| Lipid clearance and amyloid formation by serum amyloid A: exploring the links between beneficial and pathologic actions of an enigmatic protein. | J Lipid Res | 2023 | 37604227 | PubTator, text mining | PubMed |
| The Importance of Metabolic and Environmental Factors in the Occurrence of Oxidative Stress during Pregnancy. | Int J Mol Sci | 2023 | 37569340 | PubTator, text mining | PubMed |
Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis. | J Transl Autoimmun | 2023 | 37520890 | PubTator, text mining | PubMed |
| Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction. | Int J Mol Sci | 2023 | 37511373 | PubTator, text mining | PubMed |
| Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis. | J Transl Autoimmun | 2023 | 37484708 | PubTator, text mining | PubMed |
| Association of Plasma Vitamins and Carotenoids, DNA Methylation of LCAT, and Risk of Age-Related Macular Degeneration. | Nutrients | 2023 | 37447314 | PubTator, text mining | PubMed |
| The Sizes and Composition of HDL-Cholesterol Are Significantly Associated with Inflammation in Rheumatoid Arthritis Patients. | Int J Mol Sci | 2023 | 37445823 | PubTator, text mining | PubMed |
| High density lipoprotein: When to rethink too much of a good thing. | Am J Prev Cardiol | 2023 | 37434863 | PubTator, text mining | PubMed |
| Low-grade inflammation is associated with a heterogeneous lipoprotein subclass profile in an apparently healthy population sample. | Lipids Health Dis | 2023 | 37434164 | PubTator, text mining | PubMed |
| Dietary acid load and its interaction with CETP TaqB1 polymorphisms on lipid profile among patients with Type 2 diabetes mellitus. | BMC Endocr Disord | 2023 | 37407953 | PubTator, text mining | PubMed |
| Proteomic and functional analysis of HDL subclasses in humans and rats: a proof-of-concept study. | Lipids Health Dis | 2023 | 37386457 | PubTator, text mining | PubMed |
| Abnormal HDL lipid and protein composition following pediatric cancer treatment: an associative study. | Lipids Health Dis | 2023 | 37301877 | PubTator, text mining | PubMed |
| HDL Subclasses and the Distribution of Paraoxonase-1 Activity in Patients with ST-Segment Elevation Acute Myocardial Infarction. | Int J Mol Sci | 2023 | 37298334 | PubTator, text mining | PubMed |
| A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease. | Pharmaceutics | 2023 | 37242746 | PubTator, text mining | PubMed |
| Sphingosine-1-Phosphate Signaling in Cardiovascular Diseases. | Biomolecules | 2023 | 37238688 | PubTator, text mining | PubMed |
| HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy. | Circ Res | 2023 | 37228232 | PubTator, text mining | PubMed |
| A biomarker discovery of acute myocardial infarction using feature selection and machine learning. | Med Biol Eng Comput | 2023 | 37199891 | PubTator, text mining | PubMed |
| A commentary on the paper, 'Development and validation of a novel automatable assay for cholesterol efflux capacity'. | Biosci Rep | 2023 | 37199509 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53369/papers?page=4